Report ID: SQMIG35G2300
Cell and Gene Therapy Market Size, Share, Growth Analysis, By Therapy Type (Cell Therapy, Gene Therapy), By Therapeutic class (Cardiovascular Disease, Cancer), By Delivery Method, By End-Users, By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35G2300 |
Region:
Global |
Published Date: November, 2024
Pages:
194
|
Tables:
96 |
Figures:
72
Cell and Gene Therapy Market Insights
Global Cell and Gene Therapy Market size was valued at USD 17.7 billion in 2022 and is poised to grow from USD 20.97 billion in 2023 to USD 81.55 billion by 2031, growing at a CAGR of 18.50% during the forecast period (2024-2031).
Advancements in genetic engineering and growing investments in cell research are projected to primarily augment the demand for cell and gene therapy over the coming years. Increasing use of novel cell therapies and gene therapies to treat various diseases will also create new opportunities for cell and gene therapy companies going forward. Rising emphasis on improving patient care, growing demand for novel treatments and therapies, and surging incidence of chronic diseases are other factors that play a crucial role in cell and gene therapy market growth in the future. Increasing regulatory approvals for novel therapies and rapidly rising popularity of personalized medicine are also expected to offer new business scope for cell and gene therapy companies in the long run. However, high costs of advanced therapies, limited reimbursement, and limited accessibility to novel treatments are slated to be key constraints slowing down cell and gene therapy adoption.
Cell and Gene Therapy Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
